UCMOK
GILD icon

United Capital Management of KS’s Gilead Sciences GILD Stock Holding History

United Capital Management of KS’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,061
Closed -$470K – 93
2020
Q4 		$470K Buy
8,061
+402
+5% +$24.3K 0.21% 72
2020
Q3 		$484K Buy
7,659
+409
+6% +$28.4K 0.25% 71
2020
Q2 		$558K Buy
+7,250
New +$556K 0.33% 66

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

United Capital Management of KS's GILD Position: Q1 2021 in Review

United Capital Management of KS sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 8,061 shares — an estimated $470K sold.

United Capital Management of KS first reported a position in GILD in Q2 2020 and held it in 3 quarters. The position peaked at $558K in Q2 2020. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • United Capital Management of KS reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • United Capital Management of KS sold 8,061 Gilead Sciences shares in Q1 2021, an estimated $470K.
  • United Capital Management of KS first reported a position in Gilead Sciences in Q2 2020 and held it in 3 quarters.
  • United Capital Management of KS's Gilead Sciences position peaked at $558K in Q2 2020.
  • 1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on United Capital Management of KS's 13F filing for Q1 2021, filed 27 Apr 2021.